Search Tag: rare diseases

ICU Management

2024 16 May

<marquee behavior="slide" direction="left" scrollamount="30" style="text-align: center;"> <h2><b>Find MENA Congress for Rare Diseases on Social Media</b> </font></h2><div style="text-align: center;"> <a href="https://twitter.com/menararedisease" target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65>Read more

ICU Management

2024 20 Feb

  Individualized therapies and the integration of the patient's perspective are becoming increasingly important.   February 29 is Rare Disease Day. On this occasion, the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH (AOP Health) takes a look at the challenges faced by patients with rare diseases and highlights the trends...Read more

ICU Management

2024 24 Jan

Seasoned leader in drug discovery and development   ‍OrphAI Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases the appointment of Jay S. Fine, Ph.D. to its Board of Directors.     Dr. Fine has a strong track record of drug discovery and development leadership in respiratory diseases,...Read more

Cardiology Management

2023 06 Dec

AOP Health: Bianca Tan Assuming New Position as Therapeutic Area Director Cardiology and Pulmonology.   In 2006, Bianca Tan started her career at AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company with headquarters in Vienna that specializes in rare diseases and intensive care medicine. She has worked in various departments...Read more

ICU Management

2023 14 Nov

To ensure the availability of new therapies for rare diseases, a functioning cooperation between the public sector, academic research and research-based companies is crucial. With this in mind, Vienna's City Councilor for Health, Social Affairs and Sport, Peter Hacker, paid the Austrian pharmaceutical company AOP Orphan Pharmaceuticals GmbH ("AOP Health")...Read more

Executive Health Management

2023 25 Feb

Read more

Executive Health Management

2019 22 May

How can healthcare accelerate the implementation of the science?   Where is Personalised Medicine (PM) already improving the lives of patients and what is needed to make it the standard of care across multiple conditions?     What’s your brief at the PMC?   I have a science and genetics background and bring scientific...Read more

Executive Health Management

2015 27 Feb

Rare Disease Day is observed on the final day of February each year. What began as a European event has become a worldwide campaign, with thousands of events taking place in dozens of countries. This year, the theme is “Living with a Rare Disease”, which recognises the millions of family members and friends supporting patients with rare diseases. The...Read more

Pharmacy Management

2015 12 Jan

The European Medical Agency (EMA) has shown its support for a record number of orphan medicines in 2014. Out of a total of 82 medicines for human use, 17 are indicated for the treatment of a rare disease.  EMA has given positive opinions on 40 new non-orphan drugs, three biosimilars, one drug for paediatric use and 21 generic, hybrid and informed consent...Read more